De Pere selects new Fire Chief to replace retiring Matzke, set to start June 9
Battalion Chief Brett Jansen will become the new chief effective on June 9, officials announced on Monday evening.
Appleton's Lamers Dairy brings back 'Cones for a Cause' to raise money during June Dairy Month
Jansen, a long-time member with De Pere Fire Rescue, will step into the role after Assistant Fire Chief Jack Mlnrik finishes his time as the interim chief.
Chief Jansen has served De Pere for nearly 20 years, starting as a firefighter/paramedic in 2006, until he became a Lieutenant in 2019. His current title of Battalion Chief was earned in 2022.
The 2021 Wisconsin State Firefighter of the Year, Jansen, is also the Emergency Medical Services Director, with years of experience.
Fire Department Lieutenant in Wisconsin uses chainsaw to create artful park bench
Mayor James Boyd released the following statement regarding the selection:
'Battalion Chief Jansen is an exceptional leader, and we're excited to see him step into the role of Fire Chief for our community. The City of De Pere has long taken pride in the strength of its public safety services and overall quality of life. We're confident that Chief Jansen will not only uphold these high standards but also lead the department forward with professionalism, innovation, and a forward-thinking approach to fire and emergency response.'
De Pere Mayor James Boyd
City Manager Kim Flom added the following statement:
'We are excited to have Brett on board as the next Fire Chief. His commitment to the community and to the continued strength of the organization were evident through the recruitment process.'
City Manager Kim Flom
No additional details were provided.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
an hour ago
- The Hill
CDC confirms at least 85 people experienced THC sickness from pizza place in Wisconsin
STOUGHTON, Wis. (WFRV) – The Centers for Disease Control and Prevention (CDC) released a report about nine months after an incident at a Wisconsin pizza parlor where THC-infused oil was used to prepare dough. According to the report, at least 85 individuals, ranging from 1 to 91 years old, consumed food from the pizza shop in Stoughton, Wisconsin, between Oct. 22 and 24. The CDC said that the restaurant was in a building with a shared kitchen utilized by a state-licensed edible THC vendor. Initial reports came as emergency medical services in the area reported to Public Health Madison and Dane County (PHMDC) that seven people had been taken to local hospitals for symptoms such as dizziness, sleepiness and anxiety. Each individual reported eating from the same local restaurant. The seven individuals were treated at a Stoughton hospital with THC intoxication symptoms. One person who had eaten pizza from the same place reported that they had a positive THC test result without knowingly consuming any, prompting an outbreak investigation. The restaurant closed immediately on Oct. 24, confirming to PHMDC about the THC vendor in the shared kitchen. According to the CDC report, the restaurant owner confirmed that they ran out of cooking oil on Oct. 22, using some from the shared kitchen to prepare dough. Further investigation revealed that the oil used tested positive for THC, as the restaurant mistakenly used THC-infused oil from the cooperative kitchen to prepare dough. No criminal charges were filed as police deemed the contamination to be unintentional. The restaurant reopened on Oct. 26 after deep cleaning and sanitation procedures approved by the Wisconsin Food Code. The CDC report stated the following, '85 persons who responded to a health department questionnaire reported symptoms consistent with THC intoxication that occurred within 5 hours after eating food from a pizza restaurant.' The restaurant apologized for the incident after initial reports from October 2024.
Newsweek
a day ago
- Newsweek
Doctor Raises Concerns Over Medical Cannabis Use With Cancer Treatment
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Despite its growing popularity among cancer patients for managing symptoms like nausea, pain and reduced appetite, a new study has warned that the use of medicinal cannabis could make immunotherapy less effective. This is the warning of Australian medical cannabis advocate Dr. Ben Jansen, whose newly-published review paper poses the question: "Are cannabinoids with cancer immunotherapy contributing to early death?" "As both a physician involved in the medicinal cannabis industry and an advocate for patient care, I find the discussion and patient informed consent around this interaction critical," Jansen wrote in his study. "Three key studies on this topic offer preliminary data suggesting a potential reduction in immunotherapy efficacy from cannabis use," he continued. "Though the results remain limited and controversial, warranting caution and additional research." Medical marijuana over official looking subscription document. Medical marijuana over official looking subscription document. thegoodphoto/Getty Images The first study looked into patients receiving the immunotherapy drug nivolumab for advanced cancers, including lung cancer, renal cell carcinoma and melanoma. It compared those on nivolumab alone (89 patients) and those on both nivolumab and cannabis (51 patients). The findings, Jansen noted, showed a significantly lower treatment response rate in patients using cannabis than in those on just nivolumab (15.9 vs. 37.5 percent.) The analysis excluded patients with advanced disease with survival of less than two months. "This suggests that patients using cannabis were approximately three times more likely to have a poor response to immunotherapy. Notably, cannabis use did not significantly impact progression-free survival or overall survival," Jansen wrote. Building on this, the second study compared 34 patients prescribed both immunotherapy and cannabis with 68 patients receiving the cancer treatment alone. That study found that tumors tended to take less than three-and-a-half months to grow or spread in the patients taking cannabis, as compared to more than a year for patients on immunotherapy alone. It also found the median overall survival time for cannabis users was 6.4 months compared to 28.5 months for non-users. A colourful illustration representing immune cells and white blood cells. A colourful illustration representing immune cells and white blood cells. quantic69/Getty Images It should be noted that both studies had inherent limitations—including small sample sizes and a focus on inhaled cannabis, rather than the orally-administered versions Jansen notes is favored in his experience with patients. Jansen added: "Factors such as smoking and other lifestyle elements, which heavily influence cancer risk and treatment outcomes, should be carefully considered when assessing cannabis' role in immunotherapy efficacy and cancer progression, and when interpreting the studies." The third study looked at 105 patients with tumors developing in solid organs—e.g. the breast, lung or prostate—receiving immune checkpoint inhibitors, and cannabis use primarily in the form of prescribed dronabinol. (Immune checkpoint inhibitors are a form of immunotherapy treatment that works by blocking proteins that prevent the immune system from attacking cancer cells.) Cannabis use was associated with significantly worse outcomes in patients receiving immunotherapy, including a shorter median overall survival time (6.7 vs 17.3 months), a reduced progression-free survival tune (4.8 vs 9.7 months) and a markedly lower disease control rate (10.7 percent vs 37.7 percent) compared with non-users. "Notably, these negative outcomes were most evident in white patients, raising the possibility of ethnicity-related pharmacogenetic variability in cannabinoid metabolism or immune response," Jansen wrote. Other potentially important factors like performance status, comorbidities and socio-economic status may have also been unaccounted for, and though tobacco was more common among cannabis users, it may still have influenced outcomes. Dropper with medical cannabis CBD hemp oil for oral use. Dropper with medical cannabis CBD hemp oil for oral use. 24K-Production/Getty Images "One of the challenges in interpreting these studies is the inherent complexity of cannabis as a therapeutic agent," wrote Jansen. Past research, Jansen notes, has found that cannabis can suppress the immune system through its active compounds: CBD, THC and other minor cannabinoids. At the same time, however, studies undertaken both in vitro and in living organisms have suggested that cannabinoids can both kill cancer cells and stop from spreading. "These findings hold particular relevance for patients considering, or currently using, medical cannabis during immunotherapy," the doctor said. "As medical practitioners, we must weigh the benefits of cannabis in managing cancer-related symptoms (such as pain, nausea and anorexia) against its potential to compromise treatment efficacy." "While cancer has a promising role in supportive cancer care, these early findings support careful consideration when patients are concurrently undergoing immunotherapy." Jansen emphasized how important it is that clinicians ensure patients are well informed of potential interactions, particularly until we have a clearer understanding of the situation, and has called for more thorough research and trials. "Future studies should aim to control for variables such as cancer type, cannabis dosage, socio-economic status and patient lifestyle factors, particularly tobacco use, which may confound results," he concluded. Do you have a tip on a health story that Newsweek should be covering? Do you have a question about cancer? Let us know via health@ References Bar-Sela, G., Cohen, I., Campisi-Pinto, S., Lewitus, G. M., Oz-Ari, L., Jehassi, A., Peer, A., Turgeman, I., Vernicova, O., Berman, P., Wollner, M., Moskovitz, M., & Meiri, D. (2020). Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome. Cancers, 12(9), Article 9. Hadid, T., Biedny, A., Mamdani, H., Azmi, A., Kim, S., Jang, H., Uprety, D., Al Hallak, M. N., & Sukari, A. (2024). Association between cannabis use and clinical outcomes in patients with solid malignancies receiving immune checkpoint inhibitors. Therapeutic Advances in Vaccines and Immunotherapy, 12, 25151355241309095. Jansen, B. (2025). Are cannabinoids with cancer immunotherapy contributing to early death? A call for caution and further study. New Zealand Medical Journal, 138(1619). Taha, T., Meiri, D., Talhamy, S., Wollner, M., Peer, A., & Bar‐Sela, G. (2019). Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies. The Oncologist, 24(4), 549–554.
Yahoo
2 days ago
- Yahoo
NE Wisconsin reacts to no third term for Evers announcement
MADISON, Wis. (WFRV) – Governor Tony Evers announced that he will not run for a third term, prompting a flood of reaction from both sides of the aisle. Some Republicans tell Local 5 News that they feel like they have a better chance of winning back the governor's office with Evers out of the race. 'Well, to be honest Tony Evers is tough to beat and he'd be tough to beat again,' said Republican state representative David Steffen. 'He was very good at finding the middle and had kind of a folksy way about himself that connected with people.' Steffen said it's now anybody's guess who will emerge as the frontrunners in the gubernatorial race for both parties. 'It is now a jump ball there is now an opportunity for just about anyone to take this race and that's exciting for us as Republicans who are looking to take that seat back,' he said. While Steffen said he believes Evers bowing out of the race helps Republicans, others in his party think that the governor would have been a terrible candidate. A recent Marquette Law School poll found that 55 percent of Wisconsinites didn't want to see Evers run again. 'Tony Evers saw the writing on the wall: Wisconsinites are fed up with far-left policies,' said Wisconsin GOP chairperson Brian Schimming. 'While Wisconsin Democrats continue to lose the approval of voters, Republicans are already working on winning up and down the ballot.' Appleton continues Children's Week with Parks and Recreation Department's Playground Fair Washington County executive Josh Schoemann and business owner and Navy Seal Bill Berrien have launched their campaigns for governor on the GOP ticket. 'Well we need a great candidate and certainly we have the policies,' Steffen said when asked what it is going to take for Republicans to win the gubernatorial race this time around. 'We're going to be looking to cut taxes, limit government, and make everything work a little smarter for the people.' Lawrence University history professor Jerald Podair said he thinks if Evers ran again he would have won by a thin margin. He said attorney general Josh Kaul is the likely frontrunner with Evers out of the race. He said lieutenant governor Sara Rodriguez and Milwaukee mayor Cavalier Johnson are other people to keep an eye on in what could be a very crowded primary field for the Democrats. On Thursday afternoon after Evers announcement, many Democrats here in Northeast Wisconsin wanted to thank Evers for his efforts throughout his time as the state's governor. 'I think that Governor Evers was a respectable and kind leader who was really steadfast in his priorities but also knew he needed to work in a bipartisan way,' said Democratic Party of Outagamie County chairperson Emily Tseffos. 'Champion our public schools, make life more affordable for everyday Wisconsinites while dealing with a Republican controlled legislature.' Community gathers to celebrate Wautoma woman's 110th birthday 'Green Bay loves Governor Evers,' said state representative Amaad Rivera-Wagner. 'One thing he's been instrumental in is moving the coal piles, a once in a generation project, he also helped us secure funding for the NFL draft and the public safety costs afterwards.' Local Democrats said they're sad to see Governor Evers step away from politics, but that they're confident that strong candidates will emerge. 'We on the Democratic side are trying to do what's right for our neighbors, our community, state, and nation and we just need to remind the electorate of that,' Emily Tseffos said. 'I was surprised Governor Evers (didn't run for a third term), he is one of the most popular political figures in the state, popular among independents, even some Republicans,' Rivera-Wagner added. 'I think that is a testament to the work he's done.' As far as his legacy, professor Podair said that he thinks that people will remember Evers much more for his politics than his policy. 'He certainly is leaving the Democratic party better than when he found it in 2019,' Podair said. 'Tony Evers may be remembered most among Democrats as the man who slew the Scott Walker dragon. I think his legacy will be more political than policy although we will have school funding for the next 400 years thanks to him and that is policy.' The Wisconsin gubernatorial primary is in August 2026. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
